A Study of NatureU Burn on Satiety in Healthy Adults
NUBURN
A Single-Center, Single-Blind, Non-Randomized Crossover Exploratory Study of NatureU Burn With Glucose on Postprandial Satiety in Healthy Adults
2 other identifiers
interventional
14
1 country
1
Brief Summary
This single-center, single-blind, non-randomized crossover exploratory study evaluated the short-term effects of NatureU Burn on postprandial satiety in healthy adults. NatureU Burn is an oral dietary supplement containing Irvingia gabonensis seed extract and high-molecular-weight inulin. Fourteen healthy adults were enrolled, and 12 participants completed the study and were included in the effectiveness analysis. Each participant completed two test sessions separated by at least 48 hours: a reference food session with 75 g medical anhydrous glucose in 250 mL warm purified water and a test food session with one capsule of NatureU Burn plus 75 g glucose in 250 mL warm purified water. Satiety-related questionnaire scores were assessed at fasting baseline and at 30, 60, 90, 120, 180, and 240 minutes after the first bite in each session. The study assessed fullness, hunger, desire for food, and prospective food consumption, and monitored adverse reactions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 5, 2024
CompletedFirst Submitted
Initial submission to the registry
May 11, 2026
CompletedFirst Posted
Study publicly available on registry
May 19, 2026
CompletedMay 19, 2026
May 1, 2026
4 days
May 11, 2026
May 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Food-Affected Fullness Score After NatureU Burn Plus Glucose Compared With Glucose Alone
Fullness was assessed using the satiety scale. Food-affected fullness was calculated as the change from fasting baseline at each postprandial time point and compared between the NatureU Burn plus glucose test session and the glucose reference session. Fullness was assessed using the fullness item of the 100-point Satiety Rating Scale. The scale ranges from 0 to 100, with higher scores indicating greater fullness and a better satiety outcome. Food-affected fullness was calculated as the change from fasting baseline at each postprandial time point and compared between the NatureU Burn plus glucose test session and the glucose reference session. A larger positive change from baseline indicates a greater increase in fullness
Fasting baseline before food intake and 30, 60, 90, 120, 180, and 240 minutes after the first bite in each test session.
Secondary Outcomes (3)
Food-Affected Hunger Score After NatureU Burn Plus Glucose Compared With Glucose Alone
Fasting baseline before food intake and 30, 60, 90, 120, 180, and 240 minutes after the first bite in each test session
Food-Affected Desire for Food Score After NatureU Burn Plus Glucose Compared With Glucose Alone
Fasting baseline before food intake and 30, 60, 90, 120, 180, and 240 minutes after the first bite in each test session
Food-Affected Prospective Food Consumption Score After NatureU Burn Plus Glucose Compared With Glucose Alone
Fasting baseline before food intake and 30, 60, 90, 120, 180, and 240 minutes after the first bite in each test session
Study Arms (2)
Reference Food Session
ACTIVE COMPARATORParticipants consumed 75 g medical anhydrous glucose dissolved in 250 mL warm purified water during the reference food session.
NatureU Burn Plus Glucose Session
EXPERIMENTALParticipants consumed one capsule of NatureU Burn with 75 g medical anhydrous glucose dissolved in 250 mL warm purified water during the test food session.
Interventions
The reference food consisted of 75 g medical anhydrous glucose dissolved in 250 mL warm purified water.
The test food consisted of one capsule of NatureU Burn plus 75 g medical anhydrous glucose dissolved in 250 mL warm purified water. NatureU Burn is an oral dietary supplement containing Irvingia gabonensis seed extract and high-molecular-weight inulin.
Eligibility Criteria
You may qualify if:
- Healthy adults aged 18 to 50 years.
- Male or female participants.
- Body mass index within the normal range of 18.5 to 23.9 kg/m2.
- Regular habit of eating breakfast.
- Able to fast for at least 10 hours after dinner.
- Signed informed consent before enrollment.
You may not qualify if:
- Pregnant or breastfeeding women.
- Individuals engaged in heavy physical labor or high-intensity exercise.
- Chronic sleep deprivation during the previous 3 months.
- Self-reported body weight increase or decrease of at least 4 kg during the previous 3 months.
- Current use of weight-loss medications.
- Special dietary patterns, such as low-carbohydrate diet or intermittent fasting.
- Abnormal eating attitude based on eating attitude assessment.
- Serious cardiovascular, hepatic, renal, gastrointestinal, hematologic, or neurologic dysfunction.
- History of bariatric surgery.
- Major surgery or hospitalization within the previous 3 months.
- Eating disorders, including binge eating disorder, anorexia nervosa, or bulimia nervosa.
- Abnormal glucose metabolism or lipid metabolism.
- Intolerance or allergy to the test foods.
- Excessive smoking, defined as more than 15 cigarettes per day.
- Alcohol consumption greater than 15 g alcohol per day.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dao County People's Hospital
Yongzhou, Hunan, 425300, China
Related Publications (1)
Luo L, Law L, Yu M, Zhang N, Yang M. Participant Experiences from Chronic Administration of Irvingia Gabonensis Seed Extract and Inulin on the Body's Satiety: An Exploratory Analysis of a Single-Blind Clinical Trial. Current Topics in Nutraceutical Research. 2025;23(1):56-63. doi:10.37290/ctnr2641-452X.22:56-63.
RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Luke Law, Dr
OmniSolutions Laboratory Holdings Limited
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The study was described as single-blind. Participants were masked. Investigator, care provider, and outcome assessor masking were not reported.
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2026
First Posted
May 19, 2026
Study Start
April 22, 2024
Primary Completion
April 26, 2024
Study Completion
May 5, 2024
Last Updated
May 19, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to privacy protection and ethical considerations.